Financhill
Back

Apellis Pharmaceuticals Vs. Corcept Therapeutics Industry Stock Comparison

Buy
51

APLS
Apellis Pharmaceuticals

Last Price:
29.96
Seasonality Move:
22.1%
Buy
87

CORT
Corcept Therapeutics

Last Price:
59.57
Seasonality Move:
3.97%
Buy
51
Apellis Pharmaceuticals (APLS) is a Buy

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $30.02. The Score for APLS is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • APLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
87
Corcept Therapeutics (CORT) is a Buy

Is Corcept Therapeutics a Buy, Sell or Hold?

  • The current Corcept Therapeutics [CORT] share price is $59.60. The Score for CORT is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
  • CORT is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $30.02
    The current trend is relatively stagnant and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.

CORT Stock Price Chart

What is Corcept Therapeutics's stock price today?

  • The Corcept Therapeutics share price today is $59.60
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing slight buying pressure.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.4 Sell
Relative Strength Index (14 RSI): 58.06 Buy
Chaikin Money Flow: 2150169 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.93 - 28.43) Buy
Bollinger Bands (100): (29.7 - 39.56) Sell

CORT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.95 Buy
Relative Strength Index (14 RSI): 80.63 Buy
Chaikin Money Flow: 759215 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (45.11 - 51.89) Buy
Bollinger Bands (100): (31.7 - 45.68) Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.4 Buy
20-day SMA: 27.8 Buy
50-day SMA: 31.23 Sell
200-day SMA: 44.21 Sell
8-day EMA: 28.61 Buy
20-day EMA: 28.43 Buy
50-day EMA: 30.68 Sell
200-day EMA: 40.64 Sell

CORT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 51.72 Buy
20-day SMA: 49.28 Buy
50-day SMA: 44.07 Buy
200-day SMA: 32 Buy
8-day EMA: 53.06 Buy
20-day EMA: 49.83 Buy
50-day EMA: 45.17 Buy
200-day EMA: 35.31 Buy

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.75 per share, and an increase next year of $0.83 per share.

Corcept Therapeutics Earnings Growth & CORT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $0.39 per share.

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Corcept Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):